Want to see CHD full AI Analyst Report?
Revenue by Segment
Breaks down revenue by different business segments, highlighting which areas are driving growth and profitability, and where there might be challenges or opportunities for expansion.International is the clearest growth engine—consistent, above‑market gains—while U.S. (Consumer Domestic) delivers steady, seasonal revenue but is showing softer recent Q1 volumes; SPD is small, volatile and not materially accretive. Management’s call confirms the pattern: Q1 organic strength was volume‑driven (ARM & HAMMER, TheraBreath, distribution gains) and gross margins expanded, but a $25–30M commodity/transportation headwind, OxiClean distribution lapses and higher marketing spend could pressure U.S. margins and force RGM/pricing actions if productivity offsets fall short.
Date | Consumer Domestic | Consumer International | Specialty Products Division |
|---|---|---|---|
Jun 30, 2026 | $1.16B | $297.50M | $76.70M |
Mar 31, 2026 | $1.12B | $273.90M | $77.70M |
Dec 31, 2025 | $1.27B | $299.80M | $73.20M |
Sep 30, 2025 | $1.22B | $290.10M | $75.80M |
Jun 30, 2025 | $1.15B | $277.60M | $74.60M |
Mar 31, 2025 | $1.13B | $261.90M | $75.40M |
Dec 31, 2024 | $1.23B | $285.10M | $71.20M |
Sep 30, 2024 | $1.17B | $267.70M | $72.10M |
Jun 30, 2024 | $1.17B | $263.70M | $76.90M |
Mar 31, 2024 | $1.17B | $255.00M | $83.10M |